The Valsalva maneuver and Alzheimer's disease: is there a link?
暂无分享,去创建一个
[1] G. Silverberg,et al. Alzheimer's disease, normal‐pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis , 2003, The Lancet Neurology.
[2] R. Nixon,et al. A “Protease Activation Cascade” in the Pathogenesis of Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[3] A. Umemura,et al. A Phospholipase C Inhibitor Ameliorates Postischemic Neuronal Damage in Rats , 1992, Stroke.
[4] N. Secher,et al. Syncope, cerebral perfusion, and oxygenation. , 2003, Journal of applied physiology.
[5] Dirk Sander,et al. New insights into transient global amnesia: recent imaging and clinical findings , 2005, The Lancet Neurology.
[6] M. Kraut,et al. Physiologic variations in dural venous sinus flow on phase-contrast MR imaging. , 2000, AJR. American journal of roentgenology.
[7] K Ide,et al. Middle cerebral artery blood velocity during a valsalva maneuver in the standing position. , 2000, Journal of applied physiology.
[8] A. Kluger,et al. Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response , 2000, Journal of neurology, neurosurgery, and psychiatry.
[9] M. Mercken,et al. Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein , 2002, The Journal of Biological Chemistry.
[10] Michelle C LaPlaca,et al. Mechanical stretch to neurons results in a strain rate and magnitude-dependent increase in plasma membrane permeability. , 2003, Journal of neurotrauma.
[11] E. Stopa,et al. Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease , 2004, Cerebrospinal Fluid Research.
[12] R. Vassar,et al. Molecular Neurodegeneration BioMed Central Review The Alzheimer's disease β-secretase enzyme, BACE1 , 2007 .
[13] P. Scheltens,et al. Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[14] H. Matsuda. Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease , 2001, Annals of nuclear medicine.
[15] J. C. Torre. Impaired Cerebromicrovascular Perfusion: Summary of Evidence in Support of Its Causality in Alzheimer's Disease , 2000 .
[16] M. Putt,et al. Effect of acute calcium influx after mechanical stretch injury in vitro on the viability of hippocampal neurons. , 2004, Journal of neurotrauma.
[17] D. Bloch,et al. Assessment of low-flow CSF drainage as a treatment for AD , 2002, Neurology.
[18] P. Deyn,et al. Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure , 2008, Clinical Neurology and Neurosurgery.
[19] W. Le,et al. Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP , 2009, Neurobiology of Aging.
[20] W. Singer,et al. Influence of posture on the Valsalva manoeuvre. , 2001, Clinical science.
[21] D. Compston,et al. Moyamoya disease presenting as Valsalva related partial seizures , 1999, Journal of neurology, neurosurgery, and psychiatry.
[22] M. Béné,et al. Morphological alterations of the choroid plexus in late-onset Alzheimer’s disease , 2000, Acta Neuropathologica.
[23] J. C. Torre. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics , 2004, The Lancet Neurology.
[24] V A Convertino,et al. Acute manipulations of plasma volume alter arterial pressure responses during Valsalva maneuvers. , 1999, Journal of applied physiology.
[25] H. Soininen,et al. MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects , 1998, Neurobiology of Aging.
[26] D. Schwartzman,et al. Venous changes occurring during the Valsalva maneuver: evaluation by intravascular ultrasound. , 1994, The American journal of cardiology.
[27] M. Béné,et al. CHOROID PLEXUS, AGEING OF THE BRAIN, AND ALZHEIMER'S DISEASE , 2003 .
[28] B. Williams. Simultaneous cerebral and spinal fluid pressure recordings , 2005, Acta Neurochirurgica.
[29] M. Dallas,et al. Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation. , 2007, Biochemical and biophysical research communications.
[30] Steven D Chang,et al. Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. , 2002, Journal of neurosurgery.
[31] G. Hochwald,et al. Cerebrospinal fluid production and histological observations in animals with experimental obstructive hydrocephalus. , 1969, Experimental neurology.
[32] R. Itzhaki,et al. The significance of environmental factors in the etiology of Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.
[33] L. Murri,et al. Causative and susceptibility genes for Alzheimer’s disease: a review , 2003, Brain Research Bulletin.
[34] R. Bullock,et al. Realistic Expectations: The Management of Severe Alzheimer Disease , 2003, Alzheimer disease and associated disorders.
[35] S. Rehncrona,et al. Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus , 2002, Journal of neurology, neurosurgery, and psychiatry.
[36] J. Schuman,et al. Increased intraocular pressure and visual field defects in high resistance wind instrument players. , 2000, Ophthalmology.
[37] B. Matta,et al. Effects of the valsalva maneuver on cerebral circulation in healthy adults. A transcranial Doppler Study. , 1995, Stroke.
[38] S. Savolainen,et al. Prevalence of Alzheimer's Disease in Patients Investigated for Presumed Normal Pressure Hydrocephalus: A Clinical and Neuropathological Study , 1999, Acta Neurochirurgica.
[39] J. Sinclair,et al. Weight-lifters' blackout. , 1973, Lancet.
[40] Hong Qing,et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression , 2006, Proceedings of the National Academy of Sciences.
[41] G. Silverberg,et al. Novel ventriculoperitoneal shunt in Alzheimer´s disease cerebrospinal fluid biomarkers , 2004, Expert review of neurotherapeutics.
[42] Anthony F. Jorm,et al. The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.
[43] J. Godwin,et al. Pneumomediastinum: old signs and new signs. , 1996, AJR. American journal of roentgenology.
[44] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[45] A. Nirkko,et al. Transient Cerebral Circulatory Arrest Coincides With Fainting in Cough Syncope , 1995, Neurology.
[46] G. Waldemar,et al. Shunting Effects in Patients with Idiopathic Normal Pressure Hydrocephalus; Correlation with Cerebral and Leptomeningeal Biopsy Findings , 1999, Acta Neurochirurgica.
[47] M. Edwards,et al. Role of Viscoelastic Properties of Differentiated SH‐SY5Y Human Neuroblastoma Cells in Cyclic Shear Stress Injury , 2001, Biotechnology progress.
[48] M. McCarthy. Stretching the truth Why hippocampal neurons are so vulnerable following traumatic brain injury , 2003, Experimental Neurology.
[49] D. Perl,et al. Number of children is associated with neuropathology of Alzheimer's disease in women , 2009, Neurobiology of Aging.
[50] Hilkka Soininen,et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.
[51] J. Chazal,et al. Is normal pressure hydrocephalus a valid concept in 2002? A reappraisal in five questions and proposal for a new designation of the syndrome as “chronic hydrocephalus” , 2002, Journal of neurology, neurosurgery, and psychiatry.
[52] D N Levine,et al. The pathogenesis of normal pressure hydrocephalus: A theoretical analysis , 1999, Bulletin of mathematical biology.
[53] N. Knuckey,et al. Hydrocephalus decreases chloride efflux from the choroid plexus epithelium , 1993, Brain Research.
[54] B. Pike,et al. Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. , 2000, Journal of neurotrauma.
[55] David Smith,et al. Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.
[56] S. Lewis. Aetiology of transient global amnesia , 1998, The Lancet.
[57] B. Conrad,et al. Disturbance of venous flow patterns in patients with transient global amnesia , 2000, The Lancet.
[58] J. Piek,et al. Is fitness training always good for your health? , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[59] Rong Zhang,et al. Cerebral Hemodynamics During the Valsalva Maneuver: Insights From Ganglionic Blockade , 2004, Stroke.
[60] A. Mansour,et al. Recurrent retinal vein occlusion after playing a wind instrument , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[61] T. Good,et al. Pulsatile shear stress leads to DNA fragmentation in human SH‐SY5Y neuroblastoma cell line , 1999, The Journal of physiology.
[62] D. Zack,et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. , 2002, Investigative ophthalmology & visual science.
[63] R. Johnson,et al. HYDROCEPHALUS FOLLOWING VIRAL INFECTION: THE PATHOLOGY OF AQUEDUCTAL STENOSIS DEVELOPING AFTER EXPERIMENTAL MUMPS VIRUS INFECTION , 1968, Journal of neuropathology and experimental neurology.
[64] F. LaFerla. Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.
[65] R. Nixon,et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[66] A Tarnopolsky,et al. Blowing pressure, power, and spectrum in trumpet playing. , 1999, The Journal of the Acoustical Society of America.
[67] G. Heit,et al. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer’s type , 2001, Neurology.
[68] M. Dieterich,et al. Increased incidence of jugular valve insufficiency in patients with transient global amnesia , 2005, Journal of Neurology.
[69] G. Silverberg. Normal pressure hydrocephalus (NPH): ischaemia, CSF stagnation or both. , 2004, Brain : a journal of neurology.
[70] S. Shimohama. Apoptosis in Alzheimer's disease—an update , 2000, Apoptosis.
[71] R. Nixon,et al. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease , 1997, Brain Research.
[72] C. Cotman,et al. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease , 2003, Neurobiology of Disease.
[73] A. Heyman,et al. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991 .
[74] J. Tehranzadeh,et al. Spontaneous pneumothorax in a weight lifter , 1990, The American journal of sports medicine.
[75] S. Horvath,et al. Some physiological observations on French horn musicians. , 1975, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[76] T B Shea,et al. Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.
[77] A. Nègre-Salvayre,et al. Two Distinct Calcium-Dependent Mitochondrial Pathways Are Involved in Oxidized LDL–Induced Apoptosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[78] O. Kizu,et al. Proton chemical shift imaging in normal pressure hydrocephalus. , 2001, AJNR. American journal of neuroradiology.
[79] M. LaPlaca,et al. Susceptibility of hippocampal neurons to mechanically induced injury , 2003, Experimental Neurology.
[80] D. D. de Quervain,et al. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. , 2003, Human molecular genetics.
[81] R. D. Adams,et al. SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. , 1965, The New England journal of medicine.
[82] C. Cotman,et al. The Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology , 2005, Journal of neuropathology and experimental neurology.
[83] J. C. Torre,et al. Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .
[84] G. Ugolini,et al. The Neuronal Microtubule‐Associated Protein Tau Is a Substrate for Caspase‐3 and an Effector of Apoptosis , 2000 .
[85] Maximilian F. Reiser,et al. Demonstration of periventricular brain motion during a Valsalva maneuver: description of technique, evaluation in healthy volunteers and first results in hydrocephalic patients , 2001, European Radiology.
[86] W. C. O'Neill,et al. Blood pressure regulates the activity and function of the Na-K-2Cl cotransporter in vascular smooth muscle. , 2004, American journal of physiology. Heart and circulatory physiology.
[87] E. López‐Valdés,et al. Benign Valsalva's Maneuver‐Related Headache: An MRI Study of Six Cases , 1996, Headache.
[88] R. Green,et al. Vascular factors predict rate of progression in Alzheimer disease , 2007, Neurology.
[89] M. Czosnyka,et al. Cerebrospinal fluid production. , 2003, Journal of neurosurgery.
[90] J. Troncoso,et al. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease , 2003, Annals of neurology.
[91] F. Tristani,et al. The Valsalva maneuver: mechanisms and clinical implications. , 1984, Heart & lung : the journal of critical care.
[92] J. Kaye,et al. Cerebrospinal fluid production is reduced in healthy aging , 1990, Neurology.
[93] J. Noth,et al. An increased frequency of patent foramen ovale in patients with transient global amnesia. Analysis of 53 consecutive patients. , 1996, Archives of neurology.
[94] M C LaPlaca,et al. An in vitro model of traumatic neuronal injury: loading rate-dependent changes in acute cytosolic calcium and lactate dehydrogenase release. , 1997, Journal of neurotrauma.